ArticlePloS one2021
Using a One Health approach to prioritize zoonotic diseases in China, 2019.
Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Prioritization of zoonotic diseases in Bhutan through a One Health framework.One health outlook · 2026Article
- Knowledge, Attitudes, and Practices of Dog Owners Toward a Smart Health Education Pillbox for Controlling Echinococcosis - Western China, 2023-2024.China CDC weekly · 2026Article
- A paradigm shift and practical exploration in veterinary pharmacology and toxicology teaching reform in China's frontier regions under AI empowerment.Frontiers in veterinary science · 2026Review
- Economic methods and spatial scales in One Health: Results from a scoping review.One health (Amsterdam, Netherlands) · 2025Review
- A one health approach to prioritizing emerging zoonotic diseases (EZDs) in northern Vietnam.One health (Amsterdam, Netherlands) · 2025Article
- Implementing one health in Palestine: Mapping ministerial mechanisms for pandemic preparedness, zoonotic disease control, and inter-sectoral collaboration.One health (Amsterdam, Netherlands) · 2025Article
- Article
- Advancing One Health implementation and technological innovation in China: a technology assessment approach.Science in One Health · 2025Review
- A landscape analysis and one health approach to an invasive species pathway: Pet and aquaria trade in the eastern Caribbean.One health (Amsterdam, Netherlands) · 2024Article
- Spatial-temporal distribution of neglected tropical diseases burdens in China from 2005 to 2020.Infectious diseases of poverty · 2024Article
- A Generalizable Prioritization Protocol for Climate-Sensitive Zoonotic Diseases.Tropical medicine and infectious disease · 2024Article
- The application of the One Health approach in the management of five major zoonotic diseases using the World Bank domains: A scoping review.One health (Amsterdam, Netherlands) · 2024Article
- Prioritization of zoonoses of wildlife origin for multisectoral one health collaboration in Guyana, 2022.One health (Amsterdam, Netherlands) · 2024Article
- Prioritization of zoonoses for multisectoral, One Health collaboration in Somalia, 2023.One health (Amsterdam, Netherlands) · 2023Article
- Public awareness of One Health in China.One health (Amsterdam, Netherlands) · 2023Article
- Assessing and Prioritizing Zoonotic Diseases in Punjab, India: A One Health Approach.EcoHealth · 2023Article
- Surveillance and response strategies for zoonotic diseases: a comprehensive review.Science in One Health · 2023Review
- Zoonotic pathogens and diseases detected in Vietnam, 2020-2021.One health (Amsterdam, Netherlands) · 2022Article
- Towards a global One Health index: a potential assessment tool for One Health performance.Infectious diseases of poverty · 2022Review
- Etiology of acute febrile illnesses in Southern China: Findings from a two-year sentinel surveillance project, 2017-2019.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundChina is vulnerable to zoonotic disease transmission due to a large agricultural work force, sizable domestic livestock population, and a highly biodiverse ecology. To better address this threat, representatives from the human, animal, and environmental health sectors in China held a One Health Zoonotic Disease Prioritization (OHZDP) workshop in May 2019 to develop a list of priority zoonotic diseases for multisectoral, One Health collaboration.
methodsRepresentatives used the OHZDP Process, developed by the US Centers for Disease Control and Prevention (US CDC), to prioritize zoonotic diseases for China. Representatives defined the criteria used for prioritization and determined questions and weights for each individual criterion. A review of English and Chinese literature was conducted prior to the workshop to collect disease specific information on prevalence, morbidity, mortality, and Disability-Adjusted Life Years (DALYs) from China and the Western Pacific Region for zoonotic diseases considered for prioritization.
resultsThirty zoonotic diseases were evaluated for prioritization. Criteria selected included: 1) disease hazard/severity (case fatality rate) in humans, 2) epidemic scale and intensity (in humans and animals) in China, 3) economic impact, 4) prevention and control, and 5) social impact. Disease specific information was obtained from 792 articles (637 in English and 155 in Chinese) and subject matter experts for the prioritization process. Following discussion of the OHZDP Tool output among disease experts, five priority zoonotic diseases were identified for China: avian influenza, echinococcosis, rabies, plague, and brucellosis.
conclusionRepresentatives agreed on a list of five priority zoonotic diseases that can serve as a foundation to strengthen One Health collaboration for disease prevention and control in China; this list was developed prior to the emergence of SARS-CoV-2 and the COVID-19 pandemic. Next steps focused on establishing a multisectoral, One Health coordination mechanism, improving multisectoral linkages in laboratory testing and surveillance platforms, creating multisectoral preparedness and response plans, and increasing workforce capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.